STAT

STAT+: Pharmalittle: We’re reading about Lilly plant problems, FDA reorganization plans, and more

The FDA uncovered new manufacturing problems at an Eli Lilly plant that has been under scrutiny by the agency.
Source: Alex Hogan/STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because now the time has come to dive back in to the usual routine of online meetings,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Merck Deal, Weight Loss Drugs, And Lots More
Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big drugmaker into the large and growing market for eye care.
STAT1 min read
STAT+: Akili, Maker Of A Video Game To Treat ADHD, To Be Acquired For $34 Million
Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics.
STAT1 min read
Opinion: Saving Rural Psychiatry Services Will Require Higher Medicaid Payments
Unless Medicaid raises its payments to rural psychiatrists, mental health clinics across the heartland will disappear, and with it the mental health care for the patients they serve.

Related Books & Audiobooks